Literature DB >> 14738279

Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature.

Cay Anderson-Hanley1, Marne L Sherman, Raine Riggs, V Bede Agocha, Bruce E Compas.   

Abstract

A meta-analysis was conducted to evaluate possible neuropsychological effects of treatments for cancer in adults. A search revealed 30 studies, encompassing 29 eligible samples, and leading to inclusion of a total of 838 patients and control participants. A total of 173 effect sizes (Cohen's d) were extracted across 7 cognitive domains and as assessed in the literature via 3 methods of comparison (post-treatment compared with normative data, controls, or baseline performance). Statistically significant negative effect sizes were found consistently across both normative and control methods of comparison for executive function, verbal memory, and motor function. The largest effects were for executive function and verbal memory normative comparisons (-.93 and -.91, respectively). When limiting the sample of studies in the analyses to only those with relatively "less severe" diagnoses and treatments, the effects remained. While these results point toward some specific cognitive effects of systemic cancer therapies in general, no clear clinical implications can yet be drawn from these results. More research is needed to clarify which treatments may produce cognitive decrements, the size of those effects, and their duration, while ruling out a wide variety of possible mediating or moderating variables.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14738279     DOI: 10.1017/S1355617703970019

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  85 in total

1.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

Review 2.  An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.

Authors:  Yin Ting Cheung; Earl Hsien-Jie Tan; Alexandre Chan
Journal:  Support Care Cancer       Date:  2012-04-05       Impact factor: 3.603

Review 3.  Candidate mechanisms for chemotherapy-induced cognitive changes.

Authors:  Tim A Ahles; Andrew J Saykin
Journal:  Nat Rev Cancer       Date:  2007-03       Impact factor: 60.716

4.  Follow-up care for young adult survivors of cancer: lessons from pediatrics.

Authors:  Christine Eiser; Kate Absolom; Diana Greenfield; John Snowden; Robert Coleman; Barry Hancock; Helena Davies
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

5.  Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.

Authors:  Brenna C McDonald; Susan K Conroy; Dori J Smith; John D West; Andrew J Saykin
Journal:  Brain Behav Immun       Date:  2012-05-18       Impact factor: 7.217

6.  Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.

Authors:  Andrew J Saykin; Michiel B de Ruiter; Brenna C McDonald; Sabine Deprez; Daniel H S Silverman
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

7.  Medical decision-making capacity in patients with malignant glioma.

Authors:  Kristen L Triebel; Roy C Martin; Louis B Nabors; Daniel C Marson
Journal:  Neurology       Date:  2009-12-15       Impact factor: 9.910

8.  Relationships among attention function, exercise, and body mass index: a comparison between young breast cancer survivors and acquaintance controls.

Authors:  Kamnesh R Pradhan; Timothy E Stump; Patrick Monahan; Victoria Champion
Journal:  Psychooncology       Date:  2014-06-17       Impact factor: 3.894

9.  Cognitive and brain structural changes in long-term oligodendroglial tumor survivors.

Authors:  Nuria Cayuela; Esteban Jaramillo-Jiménez; Estela Càmara; Carles Majós; Noemi Vidal; Anna Lucas; Miguel Gil-Gil; Francesc Graus; Jordi Bruna; Marta Simó
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

Review 10.  Chemotherapy-related cognitive impairment in older patients with cancer.

Authors:  Kah Poh Loh; Michelle C Janelsins; Supriya G Mohile; Holly M Holmes; Tina Hsu; Sharon K Inouye; Meghan S Karuturi; Gretchen G Kimmick; Stuart M Lichtman; Allison Magnuson; Mary I Whitehead; Melisa L Wong; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.